Achilles Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 04, 2023 at 07:00 am EDT
Achilles Therapeutics plc reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 16.85 million compared to USD 17.29 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 0.44 a year ago.
For the six months, net loss was USD 34.35 million compared to USD 34.64 million a year ago. Basic loss per share from continuing operations was USD 0.86 compared to USD 0.89 a year ago.